🚀 Latest Good News!
iMeta achieves a new Impact Factor of 44.4!
⚡️iMeta (IF 44.4) ranks in the top 0.2% of journals worldwide (47/22,643)—submit your best research and join us in shaping the future of science! @WileyGlobal
https://t.co/wzLbm1Gw7W
#iMeta
🔥The iMeta Conference 2026 has come to a successful close!!!🥳
Researchers from diverse fields gathered to discuss the latest advances in information science, meta-omics, and life sciences, sparking new ideas and fostering interdisciplinary collaboration.
#iMeta#LifeScience
🔥The iMeta Conference 2026 has come to a successful close!!!🥳
Researchers from diverse fields gathered to discuss the latest advances in information science, meta-omics, and life sciences, sparking new ideas and fostering interdisciplinary collaboration.
#iMeta#LifeScience
Monocyte inflammation and adaptive immune dysfunction in severe Klebsiella pneumoniae pneumonia
💡 Severe disease features S100A8/A9/A12-high inflammatory monocytes, impaired antigen presentation, and disrupted adaptive immune coordination. https://t.co/Q8tW9ESnLs
Metal-dependent regulated cell death: Molecular architecture and translational frontiers
💡 This review explores emerging metal-dependent cell death pathways and their therapeutic potential in cancer, tissue degeneration, and immunotherapy. https://t.co/lCXLauKPZb
Spatial omics in the AI era: Technologies, algorithmic ecosystems, biological applications, and large model perspectives 🤖
💡 Compares spatial omics platforms and algorithms, highlights key challenges, and explores AI-driven advances in spatial biology.
https://t.co/mQs9vNMxof
👁️Spatial multi-omics unveils sphingolipid metabolic reprogramming within the retinal pathological niche
💡 Trem2⁺ microglia and the TREM2–SPTLC2 axis are linked to sphingolipid remodeling and retinal ganglion cell degeneration.
https://t.co/1dAlVw6BrZ
Multi-omics-driven precision medicine (MODPM) is understood as a multiscale decision architecture that links molecular heterogeneity, tissue context, and patient-level trajectories.
https://t.co/WTLFHc39RP
🧐The Human Biomarker Navigator integrates biomarkers across nine physiological systems, organs, and diseases into a comprehensive navigation framework.
#Biomarkers#SystemsBiology
https://t.co/lxLJEgoeAi
🦠 The gut microbiome is more than a community of microbes—it functions as an organ-like system shaping metabolism, immunity, and gut–brain signaling. #Gut#Microbiome@WileyHealth
https://t.co/inrOoJzRk8
Two near‐complete assemblies reveal R‐subgenome structural and centromeric divergence associated with reproductive isolation in hexaploid triticale
https://t.co/iIZ3ScBAfB
⚡️A new piece of the puzzle in recurrent pregnancy loss: Hyperoside alleviates endometrial stromal cell senescence, restores decidualization, and reduces embryo loss partly by mitigating pathological R-loop accumulation.
https://t.co/how9quT840
Environmental chemicals don’t just cause cancer—they can reshape the tumor immune microenvironment and undermine antitumor immunity and immunotherapy.@WileyHealth
https://t.co/pSvRhk532T
The gut microbiome may signal gestational diabetes risk long before diagnosis: an integrated metagenomic and lipidomic study reveals a Ruminococcus bicirculans–lactosylceramide axis linked to metabolic dysregulation and insulin signaling.@WileyHealth
https://t.co/rWwag2sVfD